INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 281 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,950,558 | +39.9% | 75,841 | +70.1% | 0.10% | +33.8% |
| Q2 2023 | $2,823,186 | +58.5% | 44,586 | +35.5% | 0.07% | +51.0% |
| Q1 2023 | $1,781,156 | +2.9% | 32,893 | +0.5% | 0.05% | 0.0% |
| Q4 2022 | $1,731,754 | +263.1% | 32,724 | +291.4% | 0.05% | +133.3% |
| Q2 2022 | $477,000 | -23.9% | 8,360 | -45.6% | 0.02% | -60.4% |
| Q2 2021 | $627,000 | +2.0% | 15,366 | -61.6% | 0.05% | +17.8% |
| Q1 2020 | $615,000 | +348.9% | 39,986 | +117.5% | 0.04% | +275.0% |
| Q3 2019 | $137,000 | -45.0% | 18,383 | +30.4% | 0.01% | -29.4% |
| Q2 2018 | $249,000 | -33.4% | 14,096 | -20.7% | 0.02% | -34.6% |
| Q1 2018 | $374,000 | -30.6% | 17,780 | -52.2% | 0.03% | -55.9% |
| Q4 2017 | $539,000 | +6.1% | 37,203 | +15.6% | 0.06% | -53.9% |
| Q3 2017 | $508,000 | +32.3% | 32,176 | +36.0% | 0.13% | +161.2% |
| Q1 2017 | $384,000 | +15.3% | 23,652 | +175.6% | 0.05% | +11.4% |
| Q2 2016 | $333,000 | -50.8% | 8,581 | -59.5% | 0.04% | -42.1% |
| Q2 2015 | $677,000 | – | 21,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |